An Open Label, Single Center, Nonrandomized Continuation Study of Cholic Acid Capsules to Treat Subjects With Inborn Errors of Bile Acid Synthesis
Phase of Trial: Phase III
Latest Information Update: 17 Aug 2016
At a glance
- Drugs Cholic acid (Primary)
- Indications Inborn genetic disorders
- Focus Therapeutic Use
- Sponsors Asklepion Pharmaceuticals; Retrophin
- 15 Aug 2016 Status changed from active, no longer recruiting to completed.
- 26 Oct 2015 Planned End Date changed from 1 Jun 2015 to 1 Jun 2016 as reported by ClinicalTrials.gov.
- 26 Oct 2015 Planned primary completion date changed from 1 Jun 2015 to 1 Jun 2016 as reported by ClinicalTrials.gov.